Literature DB >> 10352922

Insulin action in the polycystic ovary syndrome.

A Dunaif1.   

Abstract

Research on insulin action in PCOS has been intensive after the identification of insulin resistance as a feature of the syndrome in 1980. It is now clear that PCOS is a metabolic as well as a reproductive disorder and an important cause of type 2 diabetes mellitus in women. The cellular and molecular mechanisms of insulin resistance in PCOS are distinct from those in other insulin resistance syndromes. Elucidating these mechanisms promises to provide considerable insight into insulin receptor signal specificity. Conversely, insulin resistance is now known to have an important role in the pathogenesis of the reproductive disturbances of PCOS. It is thought that one or several genetic defects may cause both the insulin resistance and reproductive abnormalities characteristic of PCOS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352922     DOI: 10.1016/s0889-8529(05)70073-6

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  32 in total

Review 1.  Multiple signal transduction pathways regulate ovarian steroidogenesis.

Authors:  Jennifer R Wood; Jerome F Strauss
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Obesity and Polycystic Ovary Syndrome.

Authors:  Susan Sam
Journal:  Obes Manag       Date:  2007-04

Review 3.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

4.  Ovarian hypertension: polycystic ovary syndrome.

Authors:  Rhonda Bentley-Lewis; Ellen Seely; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 5.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

6.  Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.

Authors:  Hiroaki Negishi; Kazuki Nakao; Michiko Kimura; Hiroshi Takenaka; Michiharu Horikawa
Journal:  Reprod Med Biol       Date:  2015-03-19

7.  Surface-enhanced Raman scattering for the detection of polycystic ovary syndrome.

Authors:  Ali Momenpour; Patrícia D A Lima; Yi-An Chen; Chii-Ruey Tzeng; Benjamin K Tsang; Hanan Anis
Journal:  Biomed Opt Express       Date:  2018-01-25       Impact factor: 3.732

8.  Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome.

Authors:  C M Bruns; S T Baum; R J Colman; D A Dumesic; J R Eisner; M D Jensen; L D Whigham; D H Abbott
Journal:  Int J Obes (Lond)       Date:  2007-05-01       Impact factor: 5.095

Review 9.  GnRH pulsatility, the pituitary response and reproductive dysfunction.

Authors:  Rie Tsutsumi; Nicholas J G Webster
Journal:  Endocr J       Date:  2009-07-17       Impact factor: 2.349

10.  Serum C-reactive protein levels in normal-weight polycystic ovary syndrome.

Authors:  Ji Young Oh; Ji-Ah Lee; Hyejin Lee; Jee-Young Oh; Yeon-Ah Sung; Hyewon Chung
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.